News

Round Two getting underway

DMTC’s Medical Countermeasures Program is growing with Round 2 projects announced by the Minister for Defence Industry, the Hon Christopher Pyne MP.

Medical countermeasures (MCMs) are vaccines, therapeutics and/or diagnostics against chemical, biological and radiological threat, emerging infectious disease and pandemics.

The new projects follow on from the first round of DMTC’s MCM Program that has been underway for around 15 months.

With its priorities set by Defence, seed funding for the DMTC MCM program has been provided by CSIRO and the Defence Science & Technology Group through its Next Generation Technologies Fund (NGTF). The aim of the MCM program is to accelerate the advanced development and deployment of countermeasures, with technical expertise from industry and research partners.

Under DMTC’s proven co-investment model, funding provided by Government customer agencies is leveraged by contributions of cash and resources from industry and research partners.

The Minister’s press release is available here and more details will be available on our website as soon as contract negotiations and project agreements are complete.

 

 

Posted by DMTC Tagged: , , , ,

High honour for DMTC Program Leader

DMTC Medical Countermeasures Program leader, Felicia Pradera, has been presented with the prestigious DMTC Research Collaboration Award for her leadership of the program.

The DMTC Awards for Excellence were presented at this year’s DMTC Annual Conference Dinner at the National Gallery in Canberra.

The Awards for Excellence recognise significant contributions made by individuals and teams that have resulted in successful outcomes for DMTC and its partners.

The Research Collaboration Award presented to Dr Pradera goes to an individual who embodies the spirit of collaboration that is integral to DMTC’s strategic intent.

Seconded to the DMTC from the Defence Science and Technology (DST) Group, Dr Pradera oversees a portfolio of projects that leverage funding from CSIRO and DST Group, as well as contributions from a number of highly capable and innovative research and industry partners.

DMTC CEO, Dr Mark Hodge, said Dr Pradera was a worthy recipient of the honour.

“Felicia has made a massive contribution to the success of this program,” Dr Hodge said. “In fact, it’s not over-stating it to suggest that the program may not have even been running today without her leadership and expert oversight.

“Felicia is a valued member of the DMTC team and really has exemplified our commitment to achieving the very best outcomes for the Australian Defence Force, while also facilitating industry and supply chain development in this country.”

Dr Pradera received her award from Corporal Dan Keighran VC, who was the guest speaker at the gala dinner. After telling the remarkable story of his life and the circumstances of the battle for which he was awarded the Victoria Cross, Corporal Keighran had a simple but powerful message for the DMTC community.

“What you do, makes a difference to the safety and security of our soldiers and the ADF,” he said.

DMTC congratulates Dr Pradera and all the other award winners.

Award Winners

The Industry Partnership Award is awarded to individual researchers whose efforts contribute significantly to the capability of a DMTC Industry partner. This year’s award was awarded jointly to Gui Wang and Juan Torres from the University of Queensland for their efforts in helping Thales’ Protected Vehicles division transition research outcomes from DMTC Project 3.19 into their vehicle development program.

The Project Leadership Award is awarded to leaders of a project team who have contributed significantly to achieving project outcomes. This year’s award was awarded jointly to Ali Daliri and Lihong Su for their leadership of DMTC Project 6.04 “Land vehicle alternative material characterisation” and Yen Truong for her leadership of DMTC Project 7.33 “Advanced nanostructured fabrics”. Yen’s project involves five research and industry partners including CSIRO and DST Group.

The Early Career Award recognises the contribution of early career technical officers, engineers and scientists to DMTC projects, rewarding efforts ‘above and beyond’. It is open to technical officers, engineers and scientists, including PhD students, who are working on DMTC research projects and are aged under 35. This year’s award went to Andrew Ang from Swinburne University of Technology who has been a highly-valued team member and contributor to no fewer than four DMTC projects in the Maritime domain.

The Capability Improvement Award is awarded to the project team who achieves a significant improvement in technical capability in the area of materials and/or manufacturing technology. This year’s award winner was the High Strength Fabrics project team who have developed fragmentation resistant fabric to prototype stage. Industry partner Bruck Textiles has since adopted the technology and is marketing the fabric globally. Tony Pierlot (Project Leader – CSIRO), Ahmed Bhoyro, Ben Eu, Bin Lee, Doug Dower, Horace Billon, Liberty Wagner, Lyndon Arnold, Peter Herwig, Rajiv Padhye, Sandip Ranjan, Tim Head and Vlad Libeson.

Further details on the DMTC Medical Countermeasures program are available at http://dmtc.com.au/our-activities/medical-countermeasures/

Keighran Pradera

Corporal Dan Keighran VC presents Dr Felicia Pradera with the Research Collaboration Award.

Posted by Harry Baxter Tagged: , , ,

Medical Countermeasures EOI – Documentation Release

The Defence Materials Technology Centre (DMTC) is a not for profit collaborative venture that brings together defence industry, universities and government research agencies to develop technologies that will enhance Australia’s defence and national security capability.

The Medical Countermeasures (MCM) activity being hosted by DMTC is focused on vaccines, therapeutics and diagnostics for the protection of military and civilian personnel against Chemical Biological and Radiological (CBR) threats, emerging infectious diseases and pandemics.

Now closed, this call for Expressions of Interest for collaborative projects focused on three priority areas:

1. Point of Care Diagnostics

2. Antimicrobial Resistance and

3. Security Sensitive Biological Agents.

Proposed projects were required to have a minimum of one industry partner and one academic/research partner.

The DMTC MCM program is about translation of technology and therefore all proposed projects must be at or above the non-clinical/preclinical phase of development for vaccines and therapeutics; and a prototype for diagnostics.

The following guidance was provided to assist with applications:

– DMTC MCM EOI Information guide;

– DMTC MCM TRL Guide guide; and

– DMTC MCM Template QuadChart submission.

Quad Charts were required by no later than 1600hrs AEDT on Friday March 17, 2017. Further application rounds may be conducted in future. For more information please contact Felicia Pradera at DMTC on 03 9214 4447.

Posted by DMTC Tagged: ,